V.F. Semiglazov, P.V. Krivorotko, A.V. Komyakhov, T.Yu. Semiglazova, L.P. Gigolaeva, T.T. Tabagua, M.D. Kazantseva, A.P. Tergoeva, D.G. Ulrikh, M.V. Chervyak, V.V. Klimenko, N.S. Amirov, E.K. Zhiltsova, V.V. Semiglazov
The role of alpelisib in the treatment of PIK3CA – a mutated breast cancer
|
№11-12 / 2022
|
E.V. Artamonova (1), L.V. Bolotina (2), Zh. Gligorov (3), V.A. Gorbunova (1), N.V. Zhukov (4, 5), L.G. Zhukova (1), E.N. Imyanitov (6), E.V. Karabina (7), E.I. Kovalenko (1), M.R. Lichinitser (1), L.V. Manzyuk (1), V.F. Semiglazov (6, 8), T.Yu. Semiglazova (6, 8), D.L. Stroyakovsky (9)
RESOLUTION SUMMARIZING THE RESULTS OF THE EXPERT COUNCIL "MODERN APPROACHES TO THE TREATMENT OF HER2-NEGATIVE METASTATIC BREAST CANCER. PROSPECTS FOR THE USE OF ERIBULIN AS A PART OF COMBINATION THERAPY FOR BREAST CANCER"
|
№17 / 2016
|